Prosus leads $2.5 million pre-seed investment in developer tool startup CodeKarma

Fabricio Bloisi Group Chief Executive Officer and Executive Director Prosus N.V.
Fabricio Bloisi Group Chief Executive Officer and Executive Director - Prosus N.V.
0Comments

Prosus has led a $2.5 million pre-seed funding round in CodeKarma, a software productivity platform focused on live code intelligence for developers. The round also saw participation from Accel, Xeed Ventures, SenseAI Ventures, and Stargazer Ventures. The investment is aimed at supporting CodeKarma’s plans to enhance its AI-driven capabilities and expand into new enterprise sectors, with a particular focus on the US market.

The funding will help CodeKarma advance its technology for autonomous and self-improving software systems. The company intends to use the capital for strategic hiring and continued product development as it scales operations globally.

CodeKarma’s platform integrates real-time production insights directly into developers’ workflows. This approach allows both human developers and AI systems to identify risks, remove unused code, and improve software quality more efficiently. The company says its closed-loop feedback system is designed to continuously enhance code performance and maintainability.

Ananth Vanchi, CEO & Founder of CodeKarma, stated: “Our mission is to redefine how software systems evolve and improve; not after deployment, but continuously, as they’re being built. With the rapid adoption of AI-generated code, today’s systems are increasingly complex, resulting in larger, harder-to-manage codebases often lacking real-world context. CodeKarma bridges this critical gap by embedding deep production insights directly into the developer’s environment, empowering both humans and AI to create cleaner, smarter, and self-improving software. This funding is a strong validation of our vision from leading investors and will accelerate our global expansion into enterprise markets, help us attract exceptional talent, and drive continuous innovation across diverse tech stacks and enterprise environments.”

Dhruv Gupta of Prosus commented: “At Prosus Ventures, we’re committed to supporting ambitious teams building foundational AI-native products and deepening platform synergies. We are excited to support CodeKarma as they build a new category of developer tools purpose-built for this emerging paradigm. As AI accelerates software creation, the cost of unmanaged complexity, especially tech debt, will rise sharply. CodeKarma addresses this challenge by creating a persistent relay between production and development, delivering deployment-grounded intelligence that empowers both human and AI coders.”

Utkarsh, Tech Advisor to CodeKarma added: “We are heading into an era of self-evolving software – where reliability and intelligent adaptability are at the core, empowered by seamless collaboration between smart developers and their AI co-pilots or new age AI agents. CodeKarma is born from this vision, as a code intelligence platform built for the AI era. Ananth and I are proud to be shaping this transformative product out of India.”

CodeKarma targets industries such as e-commerce, fintech, and logistics that require ongoing visibility into large-scale codebases due to frequent deployments.

More information about CodeKarma can be found at https://codekarma.ai/



1 Comments
  • www.binance.com sign up says:
    Your comment is awaiting moderation. This is a preview; your comment will be visible after it has been approved.
    Thanks for sharing. I read many of your blog posts, cool, your blog is very good. https://accounts.binance.com/register-person?ref=IXBIAFVY
  • Related

    Paul Hudson Chief Executive Officer Sanofi SA

    Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

    Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

    Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

    Volvo announces updated share and vote count after series conversion

    The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

    Paul Hudson Chief Executive Officer Sanofi SA

    Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

    Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

    Trending

    The Weekly Newsletter

    Sign-up for the Weekly Newsletter from EU Business Daily.